View Future GrowthEuglena 과거 순이익 실적과거 기준 점검 0/6Euglena은 연평균 22.2%의 비율로 수입이 증가해 온 반면, Personal Products 산업은 연평균 10.5%의 비율로 증가했습니다. 매출은 연평균 15.8%의 비율로 증가했습니다.핵심 정보22.22%순이익 성장률27.35%주당순이익(EPS) 성장률Personal Products 산업 성장률8.70%매출 성장률15.79%자기자본이익률3.36%순이익률-0.64%다음 순이익 업데이트07 Aug 2026최근 과거 실적 업데이트공시 • Jun 01Euglena Co., Ltd. to Report Q2, 2026 Results on Aug 07, 2026Euglena Co., Ltd. announced that they will report Q2, 2026 results on Aug 07, 2026Reported Earnings • May 20First quarter 2026 earnings released: JP¥0.23 loss per share (vs JP¥3.72 loss in 1Q 2025)First quarter 2026 results: JP¥0.23 loss per share (improved from JP¥3.72 loss in 1Q 2025). Revenue: JP¥13.2b (up 11% from 1Q 2025). Net loss: JP¥32.0m (loss narrowed 94% from 1Q 2025). Revenue is forecast to grow 2.3% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings.공시 • Dec 03Euglena Co., Ltd. to Report Fiscal Year 2025 Results on Feb 13, 2026Euglena Co., Ltd. announced that they will report fiscal year 2025 results on Feb 13, 2026공시 • Sep 03Euglena Co., Ltd. to Report Q3, 2025 Results on Nov 13, 2025Euglena Co., Ltd. announced that they will report Q3, 2025 results on Nov 13, 2025공시 • Jun 03Euglena Co., Ltd. to Report Q2, 2025 Results on Aug 08, 2025Euglena Co., Ltd. announced that they will report Q2, 2025 results on Aug 08, 2025공시 • Mar 01Euglena Co., Ltd. to Report Q1, 2025 Results on May 12, 2025Euglena Co., Ltd. announced that they will report Q1, 2025 results on May 12, 2025모든 업데이트 보기Recent updatesBuy Or Sell Opportunity • Jun 15Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 13% to €1.80. The fair value is estimated to be €2.25, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.1% over the last 3 years. Earnings per share has grown by 66%.공시 • Jun 01Euglena Co., Ltd. to Report Q2, 2026 Results on Aug 07, 2026Euglena Co., Ltd. announced that they will report Q2, 2026 results on Aug 07, 2026Reported Earnings • May 20First quarter 2026 earnings released: JP¥0.23 loss per share (vs JP¥3.72 loss in 1Q 2025)First quarter 2026 results: JP¥0.23 loss per share (improved from JP¥3.72 loss in 1Q 2025). Revenue: JP¥13.2b (up 11% from 1Q 2025). Net loss: JP¥32.0m (loss narrowed 94% from 1Q 2025). Revenue is forecast to grow 2.3% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings.공시 • Feb 16Euglena Co., Ltd., Annual General Meeting, Mar 24, 2026Euglena Co., Ltd., Annual General Meeting, Mar 24, 2026.공시 • Dec 03Euglena Co., Ltd. to Report Fiscal Year 2025 Results on Feb 13, 2026Euglena Co., Ltd. announced that they will report fiscal year 2025 results on Feb 13, 2026공시 • Sep 03Euglena Co., Ltd. to Report Q3, 2025 Results on Nov 13, 2025Euglena Co., Ltd. announced that they will report Q3, 2025 results on Nov 13, 2025공시 • Aug 19Euglena Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2025Euglena Co., Ltd. provided consolidated earnings guidance for the year ending December 31, 2025. For the year, the company expects net sales of JPY 50,000 million and operating profit of JPY 2,400 million.공시 • Jun 03Euglena Co., Ltd. to Report Q2, 2025 Results on Aug 08, 2025Euglena Co., Ltd. announced that they will report Q2, 2025 results on Aug 08, 2025공시 • Mar 01Euglena Co., Ltd. to Report Q1, 2025 Results on May 12, 2025Euglena Co., Ltd. announced that they will report Q1, 2025 results on May 12, 2025공시 • Feb 14Euglena Co., Ltd., Annual General Meeting, Mar 28, 2025Euglena Co., Ltd., Annual General Meeting, Mar 28, 2025.공시 • Dec 03Euglena Co., Ltd. to Report Fiscal Year 2024 Results on Feb 14, 2025Euglena Co., Ltd. announced that they will report fiscal year 2024 results on Feb 14, 2025Reported Earnings • Nov 13Third quarter 2024 earnings released: JP¥5.73 loss per share (vs JP¥2.98 loss in 3Q 2023)Third quarter 2024 results: JP¥5.73 loss per share (further deteriorated from JP¥2.98 loss in 3Q 2023). Revenue: JP¥11.6b (up 3.1% from 3Q 2023). Net loss: JP¥781.0m (loss widened 124% from 3Q 2023). Revenue is forecast to grow 2.1% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings.공시 • Aug 27Euglena Co., Ltd. to Report Q3, 2024 Results on Nov 11, 2024Euglena Co., Ltd. announced that they will report Q3, 2024 results on Nov 11, 2024공시 • Aug 14Euglena Co., Ltd. Revises Consolidated Earnings Guidance for the Year Ended December 31, 2024Euglena Co., Ltd. revised consolidated earnings guidance for the year ended December 31, 2024. for the year, the company expects Net sales of JPY 48,000 million.New Risk • Aug 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.7% average weekly change). Shareholders have been diluted in the past year (16% increase in shares outstanding).공시 • Jun 02Euglena Co., Ltd. to Report Q2, 2024 Results on Aug 08, 2024Euglena Co., Ltd. announced that they will report Q2, 2024 results on Aug 08, 2024공시 • May 17Euglena Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ended December 31, 2024Euglena Co., Ltd. provided consolidated earnings guidance for the year ended December 31, 2024. for the year, the company expects Net sales of JPY 52,500 million.Reported Earnings • May 16First quarter 2024 earnings released: EPS: JP¥1.48 (vs JP¥1.45 loss in 1Q 2023)First quarter 2024 results: EPS: JP¥1.48 (up from JP¥1.45 loss in 1Q 2023). Revenue: JP¥11.2b (up 2.9% from 1Q 2023). Net income: JP¥191.0m (up JP¥358.0m from 1Q 2023). Profit margin: 1.7% (up from net loss in 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has fallen by 22% per year, which means it is performing significantly worse than earnings.공시 • Mar 29Euglena Co., Ltd. to Report Q1, 2024 Results on May 13, 2024Euglena Co., Ltd. announced that they will report Q1, 2024 results on May 13, 2024Reported Earnings • Mar 26Full year 2023 earnings released: JP¥22.75 loss per share (vs JP¥23.83 loss in FY 2022)Full year 2023 results: JP¥22.75 loss per share (improved from JP¥23.83 loss in FY 2022). Revenue: JP¥46.5b (up 4.7% from FY 2022). Net loss: JP¥2.65b (flat on FY 2022). Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has fallen by 22% per year, which means it is performing significantly worse than earnings.공시 • Feb 16Euglena Co., Ltd., Annual General Meeting, Mar 19, 2024Euglena Co., Ltd., Annual General Meeting, Mar 19, 2024.Reported Earnings • Feb 16Full year 2023 earnings released: JP¥22.75 loss per share (vs JP¥23.83 loss in FY 2022)Full year 2023 results: JP¥22.75 loss per share (improved from JP¥23.83 loss in FY 2022). Revenue: JP¥46.5b (up 4.7% from FY 2022). Net loss: JP¥2.65b (flat on FY 2022). Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has fallen by 22% per year, which means it is performing significantly worse than earnings.공시 • Jan 25Zenhoren Co.,Ltd. (TSE:5845) agreed to acquire 18.93% stake in Okinawa Basketball Co., Ltd from Euglena Co., Ltd. (TSE:2931) for ¥360 million.Zenhoren Co.,Ltd. (TSE:5845) agreed to acquire 18.93% stake in Okinawa Basketball Co., Ltd from Euglena Co., Ltd. (TSE:2931) for ¥360 million on January 24, 2024. As part of acquisition, 480 shares will be acquired for ¥0.75 million. The transaction is expected to complete on January 31, 2024.공시 • Jan 12Euglena Co., Ltd. (TSE:2931) agreed to acquire Saticine Medical Co., Ltd.Euglena Co., Ltd. (TSE:2931) agreed to acquire Saticine Medical Co., Ltd. on January 10, 2024.Board Change • Jan 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 3 highly experienced directors. Independent Outside Director Aiko Mochizuki was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.공시 • Dec 05Euglena Co., Ltd. to Report Fiscal Year 2023 Results on Feb 14, 2024Euglena Co., Ltd. announced that they will report fiscal year 2023 results on Feb 14, 2024Reported Earnings • Nov 15Third quarter 2023 earnings released: JP¥2.98 loss per share (vs JP¥15.91 loss in 3Q 2022)Third quarter 2023 results: JP¥2.98 loss per share (improved from JP¥15.91 loss in 3Q 2022). Revenue: JP¥11.3b (down 6.5% from 3Q 2022). Net loss: JP¥349.0m (loss narrowed 81% from 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.공시 • Sep 02Euglena Co., Ltd. to Report Q3, 2023 Results on Nov 13, 2023Euglena Co., Ltd. announced that they will report Q3, 2023 results on Nov 13, 2023Reported Earnings • Aug 16Second quarter 2023 earnings releasedSecond quarter 2023 results: JP¥6.38 loss per share. Net loss: JP¥747.0m (flat on 2Q 2022). Revenue is forecast to stay flat during the next 3 years compared to a 5.1% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has fallen by 6% per year.공시 • Jun 28Euglena Co., Ltd. to Report Q2, 2023 Results on Aug 14, 2023Euglena Co., Ltd. announced that they will report Q2, 2023 results on Aug 14, 2023Reported Earnings • May 17First quarter 2023 earnings releasedFirst quarter 2023 results: JP¥1.45 loss per share. Net loss: JP¥167.0m (flat on 1Q 2022). Revenue is forecast to grow 1.0% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 1% per year.Reported Earnings • Mar 31Full year 2022 earnings released: JP¥23.83 loss per share (vs JP¥44.51 loss in FY 2021)Full year 2022 results: JP¥23.83 loss per share (improved from JP¥44.51 loss in FY 2021). Revenue: JP¥44.4b (up 46% from FY 2021). Net loss: JP¥2.67b (loss narrowed 43% from FY 2021). Revenue is forecast to stay flat during the next 3 years compared to a 4.8% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.공시 • Feb 16Euglena Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending Dec. 31, 2023Euglena Co., Ltd. provided consolidated earnings guidance for the fiscal year ending Dec. 31, 2023. The company expects net sales to be JPY 45,000 million.공시 • Feb 15Euglena Co., Ltd., Annual General Meeting, Mar 24, 2023Euglena Co., Ltd., Annual General Meeting, Mar 24, 2023.Reported Earnings • Feb 14Full year 2022 earnings released: JP¥23.83 loss per share (vs JP¥44.51 loss in FY 2021)Full year 2022 results: JP¥23.83 loss per share (improved from JP¥44.51 loss in FY 2021). Revenue: JP¥44.4b (up 46% from FY 2021). Net loss: JP¥2.67b (loss narrowed 43% from FY 2021). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.공시 • Feb 08Euglena Co., Ltd. announced that it has received ¥7.7999475 billion in funding from Marui Group Co., Ltd., Rohto Pharmaceutical Co.,Ltd., Mazda Motor Corporation, Dai-ichi Life Holdings, Inc.On February 6, 2023, Euglena Co., Ltd. closed the transaction.공시 • Jan 20Euglena Co., Ltd. announced that it expects to receive ¥7.7999475 billion in funding from Marui Group Co., Ltd., Rohto Pharmaceutical Co.,Ltd.Euglena Co., Ltd. announced that it will issue 3,208,500 common shares at a price of ¥935 for gross proceeds of ¥2,999,947,500 and 48 convertible bond-type bonds with stock acquisition rights at a price of ¥100,000,000 for gross proceeds of ¥4,800,000,000 for aggregate gross proceeds of ¥4,785,000,000 on January 19, 2023. The transaction will include participation from Marui Group Co., Ltd. of 2,139,000 shares and Rohto Pharmaceutical Co.,Ltd. of 1,069,500 shares post completion of the transaction. The company is issuing securities through third party allotment. The 10th stock acquisition rights are convertible into 5,133,689 shares. The transaction is expected to close on February 6, 2023. The transaction has been approved by the board of directors of the company.공시 • Dec 28Euglena Co., Ltd. to Report Fiscal Year 2022 Results on Feb 13, 2023Euglena Co., Ltd. announced that they will report fiscal year 2022 results on Feb 13, 2023공시 • Nov 17Euglena Co., Ltd. Provides Consolidated Financial Guidance for the Year Ending December 31, 2022Euglena Co., Ltd. provided consolidated financial guidance for the year ending December 31, 2022. For the year, the company expects net sales of JPY 44,000 million.공시 • Aug 16Euglena Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2022Euglena Co., Ltd. provided consolidated earnings guidance for the year ending December 31, 2022. For the year, the company expects net sales of JPY 44,000 million.공시 • Jun 10Euglena Co., Ltd. to Report Q2, 2022 Results on Aug 10, 2022Euglena Co., Ltd. announced that they will report Q2, 2022 results on Aug 10, 2022공시 • May 18Euglena Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2022Euglena Co., Ltd. provided consolidated earnings guidance for the year ending December 31, 2022. For the year, the company expects net sales of JPY 48,000 million.공시 • Apr 07Euglena Co., Ltd. to Report Q1, 2022 Results on May 13, 2022Euglena Co., Ltd. announced that they will report Q1, 2022 results on May 13, 2022Reported Earnings • Apr 02Full year 2021 earnings released: JP¥44.51 loss per share (vs JP¥17.15 loss in FY 2020)Full year 2021 results: JP¥44.51 loss per share (down from JP¥17.15 loss in FY 2020). Revenue: JP¥30.5b (up 118% from FY 2020). Net loss: JP¥4.68b (loss widened 194% from FY 2020). Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.공시 • Feb 22Euglena Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2022Euglena Co., Ltd. provided consolidated earnings guidance for the year ending December 31, 2022. For the year, the company expects net sales of JPY 48,000 million.공시 • Feb 12Euglena Co., Ltd., Annual General Meeting, Mar 26, 2022Euglena Co., Ltd., Annual General Meeting, Mar 26, 2022.Reported Earnings • Feb 11Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: JP¥44.51 loss per share (down from JP¥17.15 loss in FY 2020). Revenue: JP¥30.5b (up 118% from FY 2020). Net loss: JP¥4.68b (loss widened 194% from FY 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.공시 • Nov 27Euglena Co., Ltd. Provides Earnings Guidance for the Period from October 1, 2020 to December 31, 2021Euglena Co., Ltd. provided earnings guidance for the period from October 1, 2020 to December 31, 2021. For the period, the company expects net sales of ¥33,000 million.공시 • May 25Euglena Co., Ltd. Provides Consolidated Sales Guidance for the Full Year Ending September 30, 2021Euglena Co., Ltd. provided consolidated sales guidance for the full year ending September 30, 2021. For the year, the company expects net sales of JPY 22,000 million.Breakeven Date Change • May 17Forecast to breakeven in 2022The analyst covering Euglena expects the company to break even for the first time. New forecast suggests the company will make a profit of JP¥700.0m in 2022. Average annual earnings growth of 53% is required to achieve expected profit on schedule.Reported Earnings • May 17Second quarter 2021 earnings released: EPS JP¥1.75 (vs JP¥1.17 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: JP¥3.83b (up 34% from 2Q 2020). Net income: JP¥164.0m (up 51% from 2Q 2020). Profit margin: 4.3% (up from 3.8% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.공시 • Mar 16Euglena Co., Ltd., Chevron Lummus Global and Applied Research Associates, Inc. Announce Successful Production of Renewable Jet FuelEuglena Co., Ltd. (Euglena), Chevron Lummus Global (CLG) and Applied Research Associates, Inc. (ARA) are pleased to announce the successful production of renewable jet fuel from a blendstock of microalgae "euglena"-derived lipids, the first in the world to meet ASTM International D7566 Annex 6 standards. The recently produced renewable jet fuel was examined and certified to meet ASTM D7566 Annex 6 standards by a third-party analysis organization. ASTM standards are the most authoritative international fuel standards for aviation turbines produced from bio-based feedstocks. ASTM, the American Society for Testing and Materials, specify the means and testing methods for a wide variety of industrial materials.공시 • Mar 03Euglena Co., Ltd. to Report Q2, 2021 Results on May 14, 2021Euglena Co., Ltd. announced that they will report Q2, 2021 results on May 14, 2021Reported Earnings • Feb 18First quarter 2021 earnings released: JP¥3.87 loss per share (vs JP¥2.71 loss in 1Q 2020)The company reported a soft first quarter result with increased losses and weaker control over costs, although revenues improved. First quarter 2021 results: Revenue: JP¥3.91b (up 22% from 1Q 2020). Net loss: JP¥360.0m (loss widened 43% from 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has remained flat, which means it is well ahead of earnings.Is New 90 Day High Low • Feb 08New 90-day high: €7.55The company is up 9.0% from its price of €6.95 on 10 November 2020. The German market is up 12% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Personal Products industry, which is down 7.0% over the same period.공시 • Jan 22Euglena Co., Ltd. (TSE:2931) entered into an agreement to acquire Liguna, K.K. from Noriko Minamizawa and Takeshi Matsumoto.Euglena Co., Ltd. (TSE:2931) entered into an agreement to acquire Liguna, K.K. from Noriko Minamizawa and Takeshi Matsumoto on January 21, 2021. Noriko Minamizawa will sell off 51.67% stake and Takeshi Matsumoto will sell 48.33% stake. Euglena Co., Ltd. will acquire 6000 shares of Liguna and the consideration will be paid in stock. Liguna, K.K. will operate as the wholly owned subsidiary of Euglena Co., Ltd. post completion of the transaction. For the year ending May 2020, Liguna reported net worth of ¥676 million, total assets of ¥1.51 billion, sales of ¥1.83 billion and operating income of ¥109 million. The transaction is subject to approval from shareholders of Liguna and is expected to complete on March 1, 2021.공시 • Jan 07Euglena Co., Ltd. to Report Q1, 2021 Results on Feb 15, 2021Euglena Co., Ltd. announced that they will report Q1, 2021 results on Feb 15, 2021Reported Earnings • Dec 26Full year 2020 earnings released: JP¥16.00 loss per shareThe company reported a decent full year result with reduced losses and improved control over expenses, although revenues were weaker. Full year 2020 results: Revenue: JP¥13.3b (down 4.7% from FY 2019). Net loss: JP¥1.49b (loss narrowed 85% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.Is New 90 Day High Low • Dec 24New 90-day low: €6.05The company is down 20% from its price of €7.55 on 25 September 2020. The German market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 2.0% over the same period.Is New 90 Day High Low • Dec 02New 90-day low: €6.30The company is down 3.0% from its price of €6.50 on 03 September 2020. The German market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 6.0% over the same period.Reported Earnings • Nov 19Full year 2020 earnings released: JP¥16.00 loss per shareThe company reported a decent full year result with reduced losses and improved control over expenses, although revenues were weaker. Full year 2020 results: Revenue: JP¥13.3b (down 4.7% from FY 2019). Net loss: JP¥1.49b (loss narrowed 85% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.공시 • Nov 15Euglena Co., Ltd., Annual General Meeting, Dec 18, 2020Euglena Co., Ltd., Annual General Meeting, Dec 18, 2020.공시 • Oct 08Euglena Co., Ltd. to Report Fiscal Year 2020 Results on Nov 13, 2020Euglena Co., Ltd. announced that they will report fiscal year 2020 results on Nov 13, 2020공시 • Jul 30Euglena Co., Ltd. (TSE:2931) cancelled the acquisition of MEJ Inc. from Toru Koga and others.Euglena Co., Ltd. (TSE:2931) signed a share exchange contract to acquire MEJ Inc. from Toru Koga and others for approximately ¥670 million on May 8, 2019. Pursuant to the terms of the transaction Euglena Co., Ltd will issue 17 shares against one share of MEJ Inc. Euglena Co., Ltd will issue 0.9 million shares as consideration upon the delivery of MEJ Inc shares. Euglena Co., Ltd will acquire 51,850 outstanding shares of MEJ by share exchange, and make MEJ into a wholly owned subsidiary. MEJ Ltd reported total assets of ¥1.2 billion and net assets of ¥233 million as of September 30, 2018 and revenues of ¥721 million and operating profit of ¥57 million for the year ended September 30, 2018. The transaction is subject to approval by shareholders of MEJ in a meeting to be held on May 23, 2019. The transaction is resolved by the Board of Euglena Co., Ltd. The transaction is expected to complete on June 1, 2019. Plutus Consulting acted as third party appraiser and Miyake Imai Ikeda acted as legal advisor for Euglena Co., Ltd. Euglena Co., Ltd. (TSE:2931) cancelled the acquisition of MEJ Inc. from Toru Koga and others on May 8, 2020.매출 및 비용 세부 내역Euglena가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이DB:8EG 매출, 비용 및 순이익 (JPY Millions)날짜매출순이익일반관리비연구개발비31 Mar 2651,632-33028,70367531 Dec 2550,370-80528,26567530 Sep 2549,4311831,715030 Jun 2548,522-94228,28384331 Mar 2547,729-1,02332,641031 Dec 2447,618-65028,85684330 Sep 2447,675-2,43730,0701,24230 Jun 2447,326-2,00529,5741,24231 Mar 2446,799-2,29429,7341,24231 Dec 2346,482-2,65230,0301,24230 Sep 2346,136-3,06230,3921,48030 Jun 2345,613-3,12131,0611,48031 Mar 2344,407-2,87931,0431,48031 Dec 2244,392-2,67231,1091,48031 Dec 2130,510-4,67821,8661,75230 Sep 2123,291-2,43118,966030 Jun 2115,894-96311,7721,19431 Mar 2114,973-1,53911,2451,19431 Dec 2014,008-1,59410,4481,19430 Sep 2013,317-1,4869,8131,19430 Jun 2013,058-4,0803,3087,42531 Mar 2013,129-3,4852,9237,42531 Dec 1913,755-3,5563,3217,42530 Sep 1913,967-9,7989,7677,42530 Jun 1914,483-6,42416,00162431 Mar 1914,914-6,71616,59262431 Dec 1815,156-7,28517,50462430 Sep 1815,174-1,25211,51162430 Jun 1814,791-1,00411,31843131 Mar 1814,437-50810,54643131 Dec 1714,0621159,56143130 Sep 1713,8867858,70143130 Jun 1713,1533468,95135431 Mar 1712,5015468,24535431 Dec 1612,0377727,48935430 Sep 1611,1036736,96635430 Jun 169,9818995,99526231 Mar 168,6127035,10126231 Dec 157,1025264,18526230 Sep 155,9244693,244262양질의 수익: 8EG 은(는) 현재 수익성이 없습니다.이익 마진 증가: 8EG는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 8EG는 수익성이 없지만 지난 5년 동안 연평균 22.2%의 속도로 손실을 줄였습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 8EG의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: 8EG은 수익성이 없어 지난 해 수익 성장률을 Personal Products 업계(2.8%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: 8EG는 현재 수익성이 없으므로 자본 수익률이 음수(3.36%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YHousehold 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/05 13:17종가2026/07/03 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Euglena Co., Ltd.는 1명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Shima YamanakaSMBC NIKKO
공시 • Jun 01Euglena Co., Ltd. to Report Q2, 2026 Results on Aug 07, 2026Euglena Co., Ltd. announced that they will report Q2, 2026 results on Aug 07, 2026
Reported Earnings • May 20First quarter 2026 earnings released: JP¥0.23 loss per share (vs JP¥3.72 loss in 1Q 2025)First quarter 2026 results: JP¥0.23 loss per share (improved from JP¥3.72 loss in 1Q 2025). Revenue: JP¥13.2b (up 11% from 1Q 2025). Net loss: JP¥32.0m (loss narrowed 94% from 1Q 2025). Revenue is forecast to grow 2.3% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings.
공시 • Dec 03Euglena Co., Ltd. to Report Fiscal Year 2025 Results on Feb 13, 2026Euglena Co., Ltd. announced that they will report fiscal year 2025 results on Feb 13, 2026
공시 • Sep 03Euglena Co., Ltd. to Report Q3, 2025 Results on Nov 13, 2025Euglena Co., Ltd. announced that they will report Q3, 2025 results on Nov 13, 2025
공시 • Jun 03Euglena Co., Ltd. to Report Q2, 2025 Results on Aug 08, 2025Euglena Co., Ltd. announced that they will report Q2, 2025 results on Aug 08, 2025
공시 • Mar 01Euglena Co., Ltd. to Report Q1, 2025 Results on May 12, 2025Euglena Co., Ltd. announced that they will report Q1, 2025 results on May 12, 2025
Buy Or Sell Opportunity • Jun 15Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 13% to €1.80. The fair value is estimated to be €2.25, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.1% over the last 3 years. Earnings per share has grown by 66%.
공시 • Jun 01Euglena Co., Ltd. to Report Q2, 2026 Results on Aug 07, 2026Euglena Co., Ltd. announced that they will report Q2, 2026 results on Aug 07, 2026
Reported Earnings • May 20First quarter 2026 earnings released: JP¥0.23 loss per share (vs JP¥3.72 loss in 1Q 2025)First quarter 2026 results: JP¥0.23 loss per share (improved from JP¥3.72 loss in 1Q 2025). Revenue: JP¥13.2b (up 11% from 1Q 2025). Net loss: JP¥32.0m (loss narrowed 94% from 1Q 2025). Revenue is forecast to grow 2.3% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings.
공시 • Feb 16Euglena Co., Ltd., Annual General Meeting, Mar 24, 2026Euglena Co., Ltd., Annual General Meeting, Mar 24, 2026.
공시 • Dec 03Euglena Co., Ltd. to Report Fiscal Year 2025 Results on Feb 13, 2026Euglena Co., Ltd. announced that they will report fiscal year 2025 results on Feb 13, 2026
공시 • Sep 03Euglena Co., Ltd. to Report Q3, 2025 Results on Nov 13, 2025Euglena Co., Ltd. announced that they will report Q3, 2025 results on Nov 13, 2025
공시 • Aug 19Euglena Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2025Euglena Co., Ltd. provided consolidated earnings guidance for the year ending December 31, 2025. For the year, the company expects net sales of JPY 50,000 million and operating profit of JPY 2,400 million.
공시 • Jun 03Euglena Co., Ltd. to Report Q2, 2025 Results on Aug 08, 2025Euglena Co., Ltd. announced that they will report Q2, 2025 results on Aug 08, 2025
공시 • Mar 01Euglena Co., Ltd. to Report Q1, 2025 Results on May 12, 2025Euglena Co., Ltd. announced that they will report Q1, 2025 results on May 12, 2025
공시 • Feb 14Euglena Co., Ltd., Annual General Meeting, Mar 28, 2025Euglena Co., Ltd., Annual General Meeting, Mar 28, 2025.
공시 • Dec 03Euglena Co., Ltd. to Report Fiscal Year 2024 Results on Feb 14, 2025Euglena Co., Ltd. announced that they will report fiscal year 2024 results on Feb 14, 2025
Reported Earnings • Nov 13Third quarter 2024 earnings released: JP¥5.73 loss per share (vs JP¥2.98 loss in 3Q 2023)Third quarter 2024 results: JP¥5.73 loss per share (further deteriorated from JP¥2.98 loss in 3Q 2023). Revenue: JP¥11.6b (up 3.1% from 3Q 2023). Net loss: JP¥781.0m (loss widened 124% from 3Q 2023). Revenue is forecast to grow 2.1% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings.
공시 • Aug 27Euglena Co., Ltd. to Report Q3, 2024 Results on Nov 11, 2024Euglena Co., Ltd. announced that they will report Q3, 2024 results on Nov 11, 2024
공시 • Aug 14Euglena Co., Ltd. Revises Consolidated Earnings Guidance for the Year Ended December 31, 2024Euglena Co., Ltd. revised consolidated earnings guidance for the year ended December 31, 2024. for the year, the company expects Net sales of JPY 48,000 million.
New Risk • Aug 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.7% average weekly change). Shareholders have been diluted in the past year (16% increase in shares outstanding).
공시 • Jun 02Euglena Co., Ltd. to Report Q2, 2024 Results on Aug 08, 2024Euglena Co., Ltd. announced that they will report Q2, 2024 results on Aug 08, 2024
공시 • May 17Euglena Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ended December 31, 2024Euglena Co., Ltd. provided consolidated earnings guidance for the year ended December 31, 2024. for the year, the company expects Net sales of JPY 52,500 million.
Reported Earnings • May 16First quarter 2024 earnings released: EPS: JP¥1.48 (vs JP¥1.45 loss in 1Q 2023)First quarter 2024 results: EPS: JP¥1.48 (up from JP¥1.45 loss in 1Q 2023). Revenue: JP¥11.2b (up 2.9% from 1Q 2023). Net income: JP¥191.0m (up JP¥358.0m from 1Q 2023). Profit margin: 1.7% (up from net loss in 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has fallen by 22% per year, which means it is performing significantly worse than earnings.
공시 • Mar 29Euglena Co., Ltd. to Report Q1, 2024 Results on May 13, 2024Euglena Co., Ltd. announced that they will report Q1, 2024 results on May 13, 2024
Reported Earnings • Mar 26Full year 2023 earnings released: JP¥22.75 loss per share (vs JP¥23.83 loss in FY 2022)Full year 2023 results: JP¥22.75 loss per share (improved from JP¥23.83 loss in FY 2022). Revenue: JP¥46.5b (up 4.7% from FY 2022). Net loss: JP¥2.65b (flat on FY 2022). Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has fallen by 22% per year, which means it is performing significantly worse than earnings.
공시 • Feb 16Euglena Co., Ltd., Annual General Meeting, Mar 19, 2024Euglena Co., Ltd., Annual General Meeting, Mar 19, 2024.
Reported Earnings • Feb 16Full year 2023 earnings released: JP¥22.75 loss per share (vs JP¥23.83 loss in FY 2022)Full year 2023 results: JP¥22.75 loss per share (improved from JP¥23.83 loss in FY 2022). Revenue: JP¥46.5b (up 4.7% from FY 2022). Net loss: JP¥2.65b (flat on FY 2022). Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has fallen by 22% per year, which means it is performing significantly worse than earnings.
공시 • Jan 25Zenhoren Co.,Ltd. (TSE:5845) agreed to acquire 18.93% stake in Okinawa Basketball Co., Ltd from Euglena Co., Ltd. (TSE:2931) for ¥360 million.Zenhoren Co.,Ltd. (TSE:5845) agreed to acquire 18.93% stake in Okinawa Basketball Co., Ltd from Euglena Co., Ltd. (TSE:2931) for ¥360 million on January 24, 2024. As part of acquisition, 480 shares will be acquired for ¥0.75 million. The transaction is expected to complete on January 31, 2024.
공시 • Jan 12Euglena Co., Ltd. (TSE:2931) agreed to acquire Saticine Medical Co., Ltd.Euglena Co., Ltd. (TSE:2931) agreed to acquire Saticine Medical Co., Ltd. on January 10, 2024.
Board Change • Jan 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 3 highly experienced directors. Independent Outside Director Aiko Mochizuki was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
공시 • Dec 05Euglena Co., Ltd. to Report Fiscal Year 2023 Results on Feb 14, 2024Euglena Co., Ltd. announced that they will report fiscal year 2023 results on Feb 14, 2024
Reported Earnings • Nov 15Third quarter 2023 earnings released: JP¥2.98 loss per share (vs JP¥15.91 loss in 3Q 2022)Third quarter 2023 results: JP¥2.98 loss per share (improved from JP¥15.91 loss in 3Q 2022). Revenue: JP¥11.3b (down 6.5% from 3Q 2022). Net loss: JP¥349.0m (loss narrowed 81% from 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
공시 • Sep 02Euglena Co., Ltd. to Report Q3, 2023 Results on Nov 13, 2023Euglena Co., Ltd. announced that they will report Q3, 2023 results on Nov 13, 2023
Reported Earnings • Aug 16Second quarter 2023 earnings releasedSecond quarter 2023 results: JP¥6.38 loss per share. Net loss: JP¥747.0m (flat on 2Q 2022). Revenue is forecast to stay flat during the next 3 years compared to a 5.1% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has fallen by 6% per year.
공시 • Jun 28Euglena Co., Ltd. to Report Q2, 2023 Results on Aug 14, 2023Euglena Co., Ltd. announced that they will report Q2, 2023 results on Aug 14, 2023
Reported Earnings • May 17First quarter 2023 earnings releasedFirst quarter 2023 results: JP¥1.45 loss per share. Net loss: JP¥167.0m (flat on 1Q 2022). Revenue is forecast to grow 1.0% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 1% per year.
Reported Earnings • Mar 31Full year 2022 earnings released: JP¥23.83 loss per share (vs JP¥44.51 loss in FY 2021)Full year 2022 results: JP¥23.83 loss per share (improved from JP¥44.51 loss in FY 2021). Revenue: JP¥44.4b (up 46% from FY 2021). Net loss: JP¥2.67b (loss narrowed 43% from FY 2021). Revenue is forecast to stay flat during the next 3 years compared to a 4.8% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
공시 • Feb 16Euglena Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending Dec. 31, 2023Euglena Co., Ltd. provided consolidated earnings guidance for the fiscal year ending Dec. 31, 2023. The company expects net sales to be JPY 45,000 million.
공시 • Feb 15Euglena Co., Ltd., Annual General Meeting, Mar 24, 2023Euglena Co., Ltd., Annual General Meeting, Mar 24, 2023.
Reported Earnings • Feb 14Full year 2022 earnings released: JP¥23.83 loss per share (vs JP¥44.51 loss in FY 2021)Full year 2022 results: JP¥23.83 loss per share (improved from JP¥44.51 loss in FY 2021). Revenue: JP¥44.4b (up 46% from FY 2021). Net loss: JP¥2.67b (loss narrowed 43% from FY 2021). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.
공시 • Feb 08Euglena Co., Ltd. announced that it has received ¥7.7999475 billion in funding from Marui Group Co., Ltd., Rohto Pharmaceutical Co.,Ltd., Mazda Motor Corporation, Dai-ichi Life Holdings, Inc.On February 6, 2023, Euglena Co., Ltd. closed the transaction.
공시 • Jan 20Euglena Co., Ltd. announced that it expects to receive ¥7.7999475 billion in funding from Marui Group Co., Ltd., Rohto Pharmaceutical Co.,Ltd.Euglena Co., Ltd. announced that it will issue 3,208,500 common shares at a price of ¥935 for gross proceeds of ¥2,999,947,500 and 48 convertible bond-type bonds with stock acquisition rights at a price of ¥100,000,000 for gross proceeds of ¥4,800,000,000 for aggregate gross proceeds of ¥4,785,000,000 on January 19, 2023. The transaction will include participation from Marui Group Co., Ltd. of 2,139,000 shares and Rohto Pharmaceutical Co.,Ltd. of 1,069,500 shares post completion of the transaction. The company is issuing securities through third party allotment. The 10th stock acquisition rights are convertible into 5,133,689 shares. The transaction is expected to close on February 6, 2023. The transaction has been approved by the board of directors of the company.
공시 • Dec 28Euglena Co., Ltd. to Report Fiscal Year 2022 Results on Feb 13, 2023Euglena Co., Ltd. announced that they will report fiscal year 2022 results on Feb 13, 2023
공시 • Nov 17Euglena Co., Ltd. Provides Consolidated Financial Guidance for the Year Ending December 31, 2022Euglena Co., Ltd. provided consolidated financial guidance for the year ending December 31, 2022. For the year, the company expects net sales of JPY 44,000 million.
공시 • Aug 16Euglena Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2022Euglena Co., Ltd. provided consolidated earnings guidance for the year ending December 31, 2022. For the year, the company expects net sales of JPY 44,000 million.
공시 • Jun 10Euglena Co., Ltd. to Report Q2, 2022 Results on Aug 10, 2022Euglena Co., Ltd. announced that they will report Q2, 2022 results on Aug 10, 2022
공시 • May 18Euglena Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2022Euglena Co., Ltd. provided consolidated earnings guidance for the year ending December 31, 2022. For the year, the company expects net sales of JPY 48,000 million.
공시 • Apr 07Euglena Co., Ltd. to Report Q1, 2022 Results on May 13, 2022Euglena Co., Ltd. announced that they will report Q1, 2022 results on May 13, 2022
Reported Earnings • Apr 02Full year 2021 earnings released: JP¥44.51 loss per share (vs JP¥17.15 loss in FY 2020)Full year 2021 results: JP¥44.51 loss per share (down from JP¥17.15 loss in FY 2020). Revenue: JP¥30.5b (up 118% from FY 2020). Net loss: JP¥4.68b (loss widened 194% from FY 2020). Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
공시 • Feb 22Euglena Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2022Euglena Co., Ltd. provided consolidated earnings guidance for the year ending December 31, 2022. For the year, the company expects net sales of JPY 48,000 million.
공시 • Feb 12Euglena Co., Ltd., Annual General Meeting, Mar 26, 2022Euglena Co., Ltd., Annual General Meeting, Mar 26, 2022.
Reported Earnings • Feb 11Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: JP¥44.51 loss per share (down from JP¥17.15 loss in FY 2020). Revenue: JP¥30.5b (up 118% from FY 2020). Net loss: JP¥4.68b (loss widened 194% from FY 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
공시 • Nov 27Euglena Co., Ltd. Provides Earnings Guidance for the Period from October 1, 2020 to December 31, 2021Euglena Co., Ltd. provided earnings guidance for the period from October 1, 2020 to December 31, 2021. For the period, the company expects net sales of ¥33,000 million.
공시 • May 25Euglena Co., Ltd. Provides Consolidated Sales Guidance for the Full Year Ending September 30, 2021Euglena Co., Ltd. provided consolidated sales guidance for the full year ending September 30, 2021. For the year, the company expects net sales of JPY 22,000 million.
Breakeven Date Change • May 17Forecast to breakeven in 2022The analyst covering Euglena expects the company to break even for the first time. New forecast suggests the company will make a profit of JP¥700.0m in 2022. Average annual earnings growth of 53% is required to achieve expected profit on schedule.
Reported Earnings • May 17Second quarter 2021 earnings released: EPS JP¥1.75 (vs JP¥1.17 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: JP¥3.83b (up 34% from 2Q 2020). Net income: JP¥164.0m (up 51% from 2Q 2020). Profit margin: 4.3% (up from 3.8% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
공시 • Mar 16Euglena Co., Ltd., Chevron Lummus Global and Applied Research Associates, Inc. Announce Successful Production of Renewable Jet FuelEuglena Co., Ltd. (Euglena), Chevron Lummus Global (CLG) and Applied Research Associates, Inc. (ARA) are pleased to announce the successful production of renewable jet fuel from a blendstock of microalgae "euglena"-derived lipids, the first in the world to meet ASTM International D7566 Annex 6 standards. The recently produced renewable jet fuel was examined and certified to meet ASTM D7566 Annex 6 standards by a third-party analysis organization. ASTM standards are the most authoritative international fuel standards for aviation turbines produced from bio-based feedstocks. ASTM, the American Society for Testing and Materials, specify the means and testing methods for a wide variety of industrial materials.
공시 • Mar 03Euglena Co., Ltd. to Report Q2, 2021 Results on May 14, 2021Euglena Co., Ltd. announced that they will report Q2, 2021 results on May 14, 2021
Reported Earnings • Feb 18First quarter 2021 earnings released: JP¥3.87 loss per share (vs JP¥2.71 loss in 1Q 2020)The company reported a soft first quarter result with increased losses and weaker control over costs, although revenues improved. First quarter 2021 results: Revenue: JP¥3.91b (up 22% from 1Q 2020). Net loss: JP¥360.0m (loss widened 43% from 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
Is New 90 Day High Low • Feb 08New 90-day high: €7.55The company is up 9.0% from its price of €6.95 on 10 November 2020. The German market is up 12% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Personal Products industry, which is down 7.0% over the same period.
공시 • Jan 22Euglena Co., Ltd. (TSE:2931) entered into an agreement to acquire Liguna, K.K. from Noriko Minamizawa and Takeshi Matsumoto.Euglena Co., Ltd. (TSE:2931) entered into an agreement to acquire Liguna, K.K. from Noriko Minamizawa and Takeshi Matsumoto on January 21, 2021. Noriko Minamizawa will sell off 51.67% stake and Takeshi Matsumoto will sell 48.33% stake. Euglena Co., Ltd. will acquire 6000 shares of Liguna and the consideration will be paid in stock. Liguna, K.K. will operate as the wholly owned subsidiary of Euglena Co., Ltd. post completion of the transaction. For the year ending May 2020, Liguna reported net worth of ¥676 million, total assets of ¥1.51 billion, sales of ¥1.83 billion and operating income of ¥109 million. The transaction is subject to approval from shareholders of Liguna and is expected to complete on March 1, 2021.
공시 • Jan 07Euglena Co., Ltd. to Report Q1, 2021 Results on Feb 15, 2021Euglena Co., Ltd. announced that they will report Q1, 2021 results on Feb 15, 2021
Reported Earnings • Dec 26Full year 2020 earnings released: JP¥16.00 loss per shareThe company reported a decent full year result with reduced losses and improved control over expenses, although revenues were weaker. Full year 2020 results: Revenue: JP¥13.3b (down 4.7% from FY 2019). Net loss: JP¥1.49b (loss narrowed 85% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.
Is New 90 Day High Low • Dec 24New 90-day low: €6.05The company is down 20% from its price of €7.55 on 25 September 2020. The German market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 2.0% over the same period.
Is New 90 Day High Low • Dec 02New 90-day low: €6.30The company is down 3.0% from its price of €6.50 on 03 September 2020. The German market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 6.0% over the same period.
Reported Earnings • Nov 19Full year 2020 earnings released: JP¥16.00 loss per shareThe company reported a decent full year result with reduced losses and improved control over expenses, although revenues were weaker. Full year 2020 results: Revenue: JP¥13.3b (down 4.7% from FY 2019). Net loss: JP¥1.49b (loss narrowed 85% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.
공시 • Nov 15Euglena Co., Ltd., Annual General Meeting, Dec 18, 2020Euglena Co., Ltd., Annual General Meeting, Dec 18, 2020.
공시 • Oct 08Euglena Co., Ltd. to Report Fiscal Year 2020 Results on Nov 13, 2020Euglena Co., Ltd. announced that they will report fiscal year 2020 results on Nov 13, 2020
공시 • Jul 30Euglena Co., Ltd. (TSE:2931) cancelled the acquisition of MEJ Inc. from Toru Koga and others.Euglena Co., Ltd. (TSE:2931) signed a share exchange contract to acquire MEJ Inc. from Toru Koga and others for approximately ¥670 million on May 8, 2019. Pursuant to the terms of the transaction Euglena Co., Ltd will issue 17 shares against one share of MEJ Inc. Euglena Co., Ltd will issue 0.9 million shares as consideration upon the delivery of MEJ Inc shares. Euglena Co., Ltd will acquire 51,850 outstanding shares of MEJ by share exchange, and make MEJ into a wholly owned subsidiary. MEJ Ltd reported total assets of ¥1.2 billion and net assets of ¥233 million as of September 30, 2018 and revenues of ¥721 million and operating profit of ¥57 million for the year ended September 30, 2018. The transaction is subject to approval by shareholders of MEJ in a meeting to be held on May 23, 2019. The transaction is resolved by the Board of Euglena Co., Ltd. The transaction is expected to complete on June 1, 2019. Plutus Consulting acted as third party appraiser and Miyake Imai Ikeda acted as legal advisor for Euglena Co., Ltd. Euglena Co., Ltd. (TSE:2931) cancelled the acquisition of MEJ Inc. from Toru Koga and others on May 8, 2020.